We are live on ! Find out more
BSPM

Biostar Pharmaceuticals, Inc.
BSPM

Delisted

BSPM was delisted on the 18th of September, 2018.

Back to rankings

5 hedge funds and large institutions have $182K invested in Biostar Pharmaceuticals, Inc. in 2013 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more capital invested

Capital invested by funds: $142K → $182K (+$40K)

0% more funds holding

Funds holding: 5 → 5 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$21.3K
2
Renaissance Technologies
Renaissance Technologies
New York
+$6.03K
3
U
UBS
Switzerland
+$1.67K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$147K +$6.03K +1,100 +4%
Citadel Advisors
2
Citadel Advisors
Florida
$20K +$21.3K +3,885 New
California Public Employees Retirement System
3
California Public Employees Retirement System
California
$11K – – –
U
4
UBS
Switzerland
$3K +$1.67K +304 +255%
Bank of America
5
Bank of America
North Carolina
$1K – – –

BSPM Hedge Fund Activity: Q3 2013 in Review

5 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Biostar Pharmaceuticals, Inc. (BSPM) for Q3 2013, worth a combined $182K — up 28% from $142K a quarter earlier.

Fund positioning in BSPM was balanced in Q3 2013: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $21.3K.

  • 5 institutional investors held Biostar Pharmaceuticals, Inc. (BSPM) as of Q3 2013, unchanged from Q2 2013.
  • Funds reported $182K of Biostar Pharmaceuticals, Inc. stock for Q3 2013, up 28% quarter-over-quarter.
  • 1 fund opened new Biostar Pharmaceuticals, Inc. positions in Q3 2013 and 1 closed out, a net change of 0 holders.
  • The largest Biostar Pharmaceuticals, Inc. buyer in Q3 2013 was Citadel Advisors, an estimated $21.3K added.

Based on aggregated 13F filings for Q3 2013.